The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Amgen; AZD; BMS Brazil; ERYTECH Pharma; Merck Serono; MSD Oncology; SERVIER
PREDICTOR (UNICANCER GEP11): Randomized phase II study of preoperative afatinib in untreated head and neck squamous cell carcinoma (HNSCC) patients.
 
Christophe Le Tourneau
No Relationships to Disclose
 
Jean-Pierre Delord
No Relationships to Disclose
 
Gilles Dolivet
No Relationships to Disclose
 
Olivier Malard
No Relationships to Disclose
 
Jérôme Fayette
Leadership - Glycotope GmbH
Honoraria - AstraZeneca; Bristol-Myers Squibb
 
Olivier Capitain
No Relationships to Disclose
 
Caroline Even
No Relationships to Disclose
 
Caroline Hoffmann
No Relationships to Disclose
 
Sebastien Vergez
No Relationships to Disclose
 
Lionnel Geoffrois
No Relationships to Disclose
 
Frederic Rolland
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Novartis; Pfizer
Travel, Accommodations, Expenses - Novartis; Pfizer
 
Philippe Zrounba
No Relationships to Disclose
 
Laurent Laccourreye
No Relationships to Disclose
 
Joel Guigay
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MERCK SERONO (Inst)
 
Ivan Bieche
No Relationships to Disclose
 
Jerzy Klijanienko
No Relationships to Disclose
 
Nicolas Aide
No Relationships to Disclose
 
Valerie Benavent
No Relationships to Disclose
 
Jocelyn Gal
No Relationships to Disclose
 
Stephane Temam
No Relationships to Disclose